{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:34:39Z","timestamp":1789684479797,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ad.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:49:31Z","timestamp":1434613771000},"page":"609-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Skin manifestations of chronic kidney disease"],"prefix":"10.1016","volume":"106","author":[{"given":"J.C.","family":"Robles-Mendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vazquez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.05.007_bib0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ad.2015.05.007_bib0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.ajkd.2007.09.024","article-title":"Dermatological disease in patients with CKD","volume":"51","author":"Brewster","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ad.2015.05.007_bib0015","first-page":"94","article-title":"Clinical characteristics of uremic pruritus in patients undergoing haemodialysis","volume":"16","author":"Dar","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ad.2015.05.007_bib0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(03)02478-2","article-title":"Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease","volume":"49","author":"Zucker","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0025","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/sj.ki.5000251","article-title":"Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients","volume":"69","author":"Narita","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ad.2015.05.007_bib0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.5301\/jn.5000039","article-title":"Uremic pruritus","volume":"25","author":"Kfoury","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.ad.2015.05.007_bib0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1492-7535.2005.01130.x","article-title":"Uremic pruritus: a review","volume":"9","author":"Lugon","year":"2005","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ad.2015.05.007_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0272-6386(95)90102-7","article-title":"Optimal dialysis improves uremic pruritus","volume":"25","author":"Hiroshige","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ad.2015.05.007_bib0045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199209033271015","article-title":"Erythropoietin therapy for uremic pruritus","volume":"327","author":"Pascual","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2015.05.007_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.03.082","article-title":"Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus","volume":"48","author":"Chen","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ad.2015.05.007_bib0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1774-9987.2005.00271.x","article-title":"Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options","volume":"9","author":"Szepietowski","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ad.2015.05.007_bib0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000188949","article-title":"Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream","volume":"72","author":"Tarng","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.ad.2015.05.007_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/09546630802441218","article-title":"A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients","volume":"20","author":"Young","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2015.05.007_bib0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/089686080002000641","article-title":"Short-term efficacy of tacrolimus ointment in severe uremic pruritus","volume":"20","author":"Pauli-Magnus","year":"2000","journal-title":"Perit Dial Int"},{"issue":"3 Pt 1","key":"10.1016\/j.ad.2015.05.007_bib0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.050","article-title":"Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study","volume":"52","author":"Duque","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0080","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1L038","article-title":"Role of gabapentin in the treatment of uremic pruritus","volume":"42","author":"Vila","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ad.2015.05.007_bib0085","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ad.2015.05.007_bib0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","article-title":"Gabapentin and uremic pruritus in hemodialysis patients","volume":"31","author":"Razeghi","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.ad.2015.05.007_bib0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0272-6386(00)70251-4","article-title":"Ondansetron therapy for uremic pruritus in hemodialysis patients","volume":"35","author":"Ashmore","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ad.2015.05.007_bib0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0378-6323.32887","article-title":"Effect of oral granisetron in uremic pruritus","volume":"73","author":"Layegh","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2015.05.007_bib0105","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ad.2015.05.007_bib0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2004.12.052","article-title":"Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study","volume":"53","author":"Ada","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1072-7515(99)00212-4","article-title":"A study on pruritus after parathyroidectomy for secondary hyperparathyroidism","volume":"190","author":"Chou","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ad.2015.05.007_bib0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clindermatol.2007.10.017","article-title":"Cutaneous manifestations of chronic kidney disease","volume":"26","author":"Kurban","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1542-4758.2009.00405.x","article-title":"Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis","volume":"14","author":"Hari Kumar","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ad.2015.05.007_bib0130","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ad.2013.09.014","article-title":"Acquired perforating dermatosis: a report of 8 cases","volume":"105","author":"Gonz\u00e1lez-Lara","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.05.007_bib0135","first-page":"723","article-title":"Acquired reactive perforating dermatosis","volume":"11","author":"Wagner","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2015.05.007_bib0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1590\/S0365-05962013000100012","article-title":"Allopurinol in the treatment of acquired reactive perforating collagenosis","volume":"88","author":"Tilz","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0145","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.jaad.2012.10.044","article-title":"Effectiveness of topical maxacalcitol for acquired perforating disorder","volume":"68","author":"Yoshiya","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2004.02.009","article-title":"Treatment of acquired perforating dermatosis with narrowband ultraviolet B","volume":"50","author":"Ohe","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0781.2011.00634.x","article-title":"Acquired perforating dermatosis successfully treated with photodynamic therapy","volume":"28","author":"Sezer","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.ad.2015.05.007_bib0160","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2010.08.041","article-title":"Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations","volume":"65","author":"Girardi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1525-139X.2007.00399.x","article-title":"Nephrogenic systemic fibrosis: early recognition and treatment","volume":"21","author":"Knopp","year":"2008","journal-title":"Semin Dial"},{"key":"10.1016\/j.ad.2015.05.007_bib0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jca.20170","article-title":"Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: three case reports and review of literature","volume":"23","author":"Mathur","year":"2008","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ad.2015.05.007_bib0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-6143.2009.02959.x","article-title":"The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation","volume":"10","author":"Leung","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ad.2015.05.007_bib0180","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1399-0012.2008.00886.x","article-title":"Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation","volume":"22","author":"Panesar","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ad.2015.05.007_bib0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1468-3083.2011.04398.x","article-title":"Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial","volume":"27","author":"Elmholdt","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.05.007_bib0190","first-page":"1170","article-title":"UV-A1 therapy for nephrogenic systemic fibrosis","volume":"14","author":"Tran","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jca.21253","article-title":"The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange","volume":"28","author":"Poisson","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ad.2015.05.007_bib0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.pmrj.2009.05.006","article-title":"Rehabilitation in nephrogenic systemic fibrosis","volume":"1","author":"Ramaizel","year":"2009","journal-title":"PM&R"},{"key":"10.1016\/j.ad.2015.05.007_bib0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ndt\/gfh473","article-title":"Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy","volume":"20","author":"Schmook","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ad.2015.05.007_bib0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1067\/mjd.2000.110651","article-title":"Cutaneous manifestations of end-stage renal disease","volume":"43","author":"Robinson-Bostom","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.det.2008.05.006","article-title":"Calciphylaxis","volume":"26","author":"Daud\u00e9n","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2015.05.007_bib0220","first-page":"166","article-title":"Diagnosis and treatment of calciphylaxis","volume":"10","author":"Ong","year":"2012","journal-title":"Skinmed"},{"key":"10.1016\/j.ad.2015.05.007_bib0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1525-139X.2012.01109.x","article-title":"Diagnosis of common dermopathies in dialysis patients: a review and update","volume":"25","author":"Markova","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.ad.2015.05.007_bib0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0001-7310(06)73361-0","article-title":"Porphyria cutanea tarda in a dialyzed female patient","volume":"97","author":"P\u00e9rez","year":"2006","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.05.007_bib0235","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2000.105504","article-title":"Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review","volume":"42","author":"Shieh","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0240","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0365-05962011000200031","article-title":"Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine","volume":"86","author":"Guiotoku","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ad.2015.05.007_bib0245","first-page":"86","article-title":"Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: a study of 101 patients in Sari, Iran","volume":"2","author":"Hajheydari","year":"2008","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.ad.2015.05.007_bib0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0378-6323.25636","article-title":"Cutaneous manifestations in patients with chronic renal failure on hemodialysis","volume":"72","author":"Udayakumar","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2015.05.007_bib0255","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0140-6736(08)61587-1","article-title":"Mees\u2019 lines","volume":"372","author":"Chauhan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2015.05.007_bib0260","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2010.03.012","article-title":"Muehrcke's lines","volume":"123","author":"Short","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ad.2015.05.007_bib0265","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/SMJ.0b013e3181bad0ac","article-title":"Half and half nail secondary to chronic renal failure","volume":"102","author":"Lin","year":"2009","journal-title":"South Med J"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:03:47Z","timestamp":1757552627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731015002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0001731015002720"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.05.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin manifestations of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}